As of 2026-10-10, the Relative Valuation of Sarepta Therapeutics Inc (SRPT) is (34.19) USD. This relative valuation is based on P/E multiples. With the latest stock price at 17.85 USD, the upside of Sarepta Therapeutics Inc based on Relative Valuation is -291.5%.
The range of the Relative Valuation is (33.67) - (37.09) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.5x - 28.6x | 25.6x |
| Forward P/E multiples | 26.0x - 29.5x | 27.2x |
| Fair Price | (33.67) - (37.09) | (34.19) |
| Upside | -288.6% - -307.8% | -291.5% |
| Date | P/E |
| 2026-10-09 | -13.78 |
| 2026-10-08 | -14.06 |
| 2026-10-07 | -13.51 |
| 2026-10-06 | -13.37 |
| 2026-10-05 | -13.51 |
| 2026-10-02 | -13.51 |
| 2026-10-01 | -13.57 |
| 2026-09-30 | -14.07 |
| 2026-09-29 | -14.39 |
| 2026-09-28 | -14.52 |
| 2026-09-25 | -14.42 |
| 2026-09-24 | -14.20 |
| 2026-09-23 | -14.63 |
| 2026-09-22 | -16.07 |
| 2026-09-21 | -15.55 |
| 2026-09-18 | -15.53 |
| 2026-09-17 | -15.96 |
| 2026-09-16 | -15.26 |
| 2026-09-15 | -16.00 |
| 2026-09-14 | -16.15 |
| 2026-09-11 | -15.79 |
| 2026-09-10 | -15.85 |
| 2026-09-09 | -17.00 |
| 2026-09-08 | -16.17 |
| 2026-09-04 | -17.37 |
| 2026-09-03 | -17.75 |
| 2026-09-02 | -17.92 |
| 2026-09-01 | -16.47 |
| 2026-08-31 | -16.24 |
| 2026-08-28 | -16.11 |
| 2026-08-27 | -16.67 |
| 2026-08-26 | -15.03 |
| 2026-08-25 | -14.61 |
| 2026-08-24 | -14.00 |
| 2026-08-21 | -14.51 |
| 2026-08-20 | -14.84 |
| 2026-08-19 | -15.24 |
| 2026-08-18 | -13.92 |
| 2026-08-17 | -14.04 |
| 2026-08-14 | -13.98 |
| 2026-08-13 | -14.22 |
| 2026-08-12 | -14.19 |
| 2026-08-11 | -14.07 |
| 2026-08-10 | -13.27 |
| 2026-08-07 | -12.96 |
| 2026-08-06 | -12.96 |
| 2026-08-05 | -12.30 |
| 2026-08-04 | -12.66 |
| 2026-08-03 | -12.26 |
| 2026-07-31 | -11.47 |